New Urine Test For Prostate Cancer May Help Reduce Unnecessary Biopsies

Agustin Vai/Getty Images

Researchers have identified 17 unique genetic markers that are overexpressed by high-grade prostate cancers, which can be screened for accurately using a urine test. Experts say the test can help doctors identify serious cancers while also reducing unnecessary biopsies.

Prostate cancers are graded according to a Gleason score. Trusted Source The higher the grade the more likely the cancer will spread quickly and grow. This new test could potentially help with diagnosing and treating cancer earlier and with fewer invasive measures.

The health benefits of screening for prostate cancer with a standard prostate-specific antigen (PSA) blood test have historically come with the tradeoff: the potential for unnecessary, invasive procedures, such as prostate biopsies.

By: Gigen Mammoser

Source: Prostate Cancer: New Urine Test May Help Reduce Unnecessary Biopsies

Read more:

Astellas announces EC approval of Xtandi for expanded prostate cancer use PMLiVE 2d

Xtandi Astellas

European Commission

Deep Bio’s prostate cancer diagnosis software aims to enter US reimbursement market Korea Biomedical Review 5d

Business (US)Global Health

Cancer Research

First signs of prostate cancer to watch for after death of OJ Simpson Devon Live 10:15 Fri, 12 Apr

Novartis gains rights to Arvinas’ prostate cancer therapy in deal worth over $1bn PMLiVE 15:08 Fri, 12 Apr

Novartis Pharma

Biotechnology

Annual gala celebrates advances in prostate cancer research and treatment at Mount Sinai Mount Sinai 7d

Cancer Research Global Health

Cancer

Cold Francis Collins’s prostate cancer story deter men from active Surveillance? Medpage Today 09:59 Thu, 18 Apr

Health Global Health

Cancer

Urine test may determine prostate cancers’ level of aggression UPI 10:34 Fri, 19 Apr

Cancer Treatment Cancer

Health

Combined chemohormonal therapy for locally advanced prostate cancer offers extended control of PSA levels News-Medical.Net 20:21 Wed, 17 Apr

Cancer Treatment Global Health

Cancer

Inside Your Health: Prostate cancer KSTP TV 20:31 Wed, 17 Apr

Health Cancer

Hemorrhagic cystitis could occur in prostate cancer patients 1 year after radiotherapy. Why? Korea Biomedical Review 2d

Cancer Treatment Radiation

Cancer

Earlier Today

Ketone supplement boosts efficacy of prostate cancer immunotherapy News-Medical.Net 11:05

Yesterday

Garje Elucidates Biomarker-Driven Approaches Generating Excitement in Metastatic Prostate Cancer OncLive 01:01

Former NIH Chief Went Public With His Prostate Cancer To Help Others NPR 23:53 Fri, 26 Apr

Comparable Germline Variant Rates Seen Across Racial Groups in Metastatic Prostate Cancer OncLive 21:49 Fri, 26 Apr

Prostate Cancer Summit: Unveiling the Latest Strategies to Beat Prostate Cancer PR Newswire (Press Release) 19:16 Fri, 26 Apr

Increasing the efficiency of cone-beam CT based delta-radiomics using automated contours to predict radiotherapy-related toxicities in prostate cancerNature.com 10:14 Fri, 26 Apr

Thursday

European Commission approves Astellas’ drug for expanded prostate cancer Treatment Outsourcing-Pharma.com 18:50 Thu, 25 Apr

Cardiovascular risk in ADT recipients: does the type of ADT matter? Nature.com 17:46 Thu, 25 Apr

Astellas announces EC approval of Xtandi for expanded prostate cancer use PMLiVE 15:10 Thu, 25 Apr

Hemorrhagic cystitis could occur in prostate cancer patients 1 year after radiotherapy. Why? Korea Biomedical Review 10:07 Thu, 25 Apr

Breast cancer survivors at higher risk of developing second cancers News-Medical.Net 06:41 Thu, 25 Apr

Wednesday

Brachytherapy for Prostate Cancer Linked to Higher Risk of Second Pelvic Malignancy Medpage Today 22:58 Wed, 24 Apr

Enzalutamide Receives Go Ahead From European Commission in nmHSPC OncLive 19:47 Wed, 24 Apr

Prostate cancer treatment and body composition eLife 18:20 Wed, 24 Apr

Masturbating might slash risk of prostate cancer, claims expert (and more is better!) MailOnline 15:59 Wed, 24 Apr

EC approves Astellas’ Xtandi for high-risk prostate cancer treatment Pharmaceutical Technology 14:32 Wed, 24 Apr

Astellas’ XTANDITM (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment SettingAstellas Pharma (Press Release) 03:07 Wed, 24 Apr

Astellas’ XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment SettingPR Newswire (Press Release) 03:06 Wed, 24 Apr

Tuesday

Does ejaculating often reduce your risk of prostate cancer? The Conversation (UK) 20:29 Tue, 23 Apr

New Prostate Cancer Urine Test Produces Greater Diagnostic Accuracy vs Existing Tests in High-Grade Prostate Cancer OncLive 16:50 Tue, 23 Apr

How to Lower Your Prostate Cancer Risk Men’s Health 16:17 Tue, 23 Apr

What Prostate Cancer Screenings Involve Men’s Health 16:17 Tue, 23 Apr